1. Home
  2. ATRA vs GCTS Comparison

ATRA vs GCTS Comparison

Compare ATRA & GCTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRA
  • GCTS
  • Stock Information
  • Founded
  • ATRA 2012
  • GCTS 1998
  • Country
  • ATRA United States
  • GCTS United States
  • Employees
  • ATRA N/A
  • GCTS N/A
  • Industry
  • ATRA Biotechnology: Biological Products (No Diagnostic Substances)
  • GCTS Blank Checks
  • Sector
  • ATRA Health Care
  • GCTS Finance
  • Exchange
  • ATRA Nasdaq
  • GCTS Nasdaq
  • Market Cap
  • ATRA 67.9M
  • GCTS 73.7M
  • IPO Year
  • ATRA 2014
  • GCTS N/A
  • Fundamental
  • Price
  • ATRA $12.18
  • GCTS $1.34
  • Analyst Decision
  • ATRA Strong Buy
  • GCTS Strong Buy
  • Analyst Count
  • ATRA 3
  • GCTS 1
  • Target Price
  • ATRA $21.00
  • GCTS $5.00
  • AVG Volume (30 Days)
  • ATRA 59.4K
  • GCTS 251.4K
  • Earning Date
  • ATRA 08-11-2025
  • GCTS 08-12-2025
  • Dividend Yield
  • ATRA N/A
  • GCTS N/A
  • EPS Growth
  • ATRA N/A
  • GCTS N/A
  • EPS
  • ATRA 0.56
  • GCTS N/A
  • Revenue
  • ATRA $188,667,000.00
  • GCTS $6,073,000.00
  • Revenue This Year
  • ATRA N/A
  • GCTS $133.55
  • Revenue Next Year
  • ATRA N/A
  • GCTS $347.37
  • P/E Ratio
  • ATRA $21.89
  • GCTS N/A
  • Revenue Growth
  • ATRA 202.41
  • GCTS N/A
  • 52 Week Low
  • ATRA $5.01
  • GCTS $0.90
  • 52 Week High
  • ATRA $18.71
  • GCTS $3.45
  • Technical
  • Relative Strength Index (RSI)
  • ATRA 53.50
  • GCTS 51.90
  • Support Level
  • ATRA $11.70
  • GCTS $1.26
  • Resistance Level
  • ATRA $13.20
  • GCTS $1.40
  • Average True Range (ATR)
  • ATRA 0.73
  • GCTS 0.07
  • MACD
  • ATRA -0.03
  • GCTS 0.01
  • Stochastic Oscillator
  • ATRA 47.96
  • GCTS 79.31

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

About GCTS GCT Semiconductor Holding Inc. Common Stock

GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.

Share on Social Networks: